Matches in Wikidata for { <http://www.wikidata.org/entity/Q57949258> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q57949258 description "article scientifique publié en 2011" @default.
- Q57949258 description "article" @default.
- Q57949258 description "im September 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57949258 description "wetenschappelijk artikel" @default.
- Q57949258 description "наукова стаття, опублікована в грудні 2011" @default.
- Q57949258 name "Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group" @default.
- Q57949258 name "Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group" @default.
- Q57949258 type Item @default.
- Q57949258 label "Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group" @default.
- Q57949258 label "Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group" @default.
- Q57949258 prefLabel "Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group" @default.
- Q57949258 prefLabel "Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group" @default.
- Q57949258 P1433 Q57949258-62E04682-904D-4316-B3F6-3065B40AF93F @default.
- Q57949258 P1476 Q57949258-09FE550B-55C8-4B0A-9019-3DDA0D3F5AFE @default.
- Q57949258 P2093 Q57949258-57EAB7BC-8F70-4DBF-B797-19567BE9E68B @default.
- Q57949258 P2093 Q57949258-5943E1A7-9BC4-4495-A30E-A628426CA8F1 @default.
- Q57949258 P2093 Q57949258-5C3F28C2-3DDB-42A7-99DA-5860A4CC2645 @default.
- Q57949258 P2093 Q57949258-64D9A109-C313-420E-BA24-EA7321E9F9F4 @default.
- Q57949258 P2093 Q57949258-B4A69368-7247-4FC6-B3A2-F5F7CD596AC4 @default.
- Q57949258 P2093 Q57949258-B4FBAA47-E226-483D-9309-42448ACCE68C @default.
- Q57949258 P2093 Q57949258-D281C237-2367-42C4-B3B4-347E609E4C34 @default.
- Q57949258 P2093 Q57949258-DDF6F832-5332-41D3-B8D2-C698A29F0BE6 @default.
- Q57949258 P304 Q57949258-B6671185-948F-4F08-8017-40198C6BBF27 @default.
- Q57949258 P31 Q57949258-3549C15A-008E-489A-962D-08884C0F8B70 @default.
- Q57949258 P356 Q57949258-C44CF987-CF17-4469-A073-9D7FD8B2BE03 @default.
- Q57949258 P407 Q57949258-22BE163D-C65C-42E8-9EE3-C98E6E37201F @default.
- Q57949258 P433 Q57949258-C68B6BA4-60A0-4826-852F-3A0E6C3A238C @default.
- Q57949258 P478 Q57949258-EF0EE5AC-A63B-4BE6-AADA-31F23F728B13 @default.
- Q57949258 P50 Q57949258-027B19BB-0595-4F34-96B1-F930F6D365FE @default.
- Q57949258 P50 Q57949258-08C216D8-9C44-4027-B5B3-D7C066D65950 @default.
- Q57949258 P50 Q57949258-E3241DAA-A1D2-47F2-918E-6D87D52E5DA1 @default.
- Q57949258 P50 Q57949258-FE12A981-AB47-4028-A909-EC63BC6A66F1 @default.
- Q57949258 P577 Q57949258-20D12D02-E753-4FF4-882D-8EA22DA14E86 @default.
- Q57949258 P698 Q57949258-CD6C16C5-CE79-40FA-B725-9DEF0907D193 @default.
- Q57949258 P921 Q57949258-514E2284-2436-4C18-BCB8-07AE921DA9F4 @default.
- Q57949258 P921 Q57949258-543184A7-C3FC-4644-8F8B-A76B36F37C33 @default.
- Q57949258 P921 Q57949258-8ED36450-7823-43B8-9E68-968E675AFBDF @default.
- Q57949258 P356 J.EURURO.2011.08.072 @default.
- Q57949258 P698 21924547 @default.
- Q57949258 P1433 Q15763991 @default.
- Q57949258 P1476 "Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group (GETUG V01)" @default.
- Q57949258 P2093 "Aline Guillot" @default.
- Q57949258 P2093 "Aude Fléchon" @default.
- Q57949258 P2093 "Damien Pouessel" @default.
- Q57949258 P2093 "Laurent Mignot" @default.
- Q57949258 P2093 "Sophie Gourgou" @default.
- Q57949258 P2093 "Stéphane Culine" @default.
- Q57949258 P2093 "Stéphane Oudard" @default.
- Q57949258 P2093 "Sylvestre Le Moulec" @default.
- Q57949258 P304 "1251-1257" @default.
- Q57949258 P31 Q13442814 @default.
- Q57949258 P356 "10.1016/J.EURURO.2011.08.072" @default.
- Q57949258 P407 Q1860 @default.
- Q57949258 P433 "6" @default.
- Q57949258 P478 "60" @default.
- Q57949258 P50 Q42870916 @default.
- Q57949258 P50 Q56548743 @default.
- Q57949258 P50 Q57421441 @default.
- Q57949258 P50 Q87812025 @default.
- Q57949258 P577 "2011-09-10T00:00:00Z" @default.
- Q57949258 P698 "21924547" @default.
- Q57949258 P921 Q2501186 @default.
- Q57949258 P921 Q422327 @default.
- Q57949258 P921 Q974135 @default.